BIO-TECHNE Corp
For the period ended Jun 30, 2026. Filed Aug 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 24, 2026
TECH$72.82-0.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Index of Consolidated Financial Statements
| | |
|---|---|
| | Page |
| Reports of Independent Registered Public Accounting Firm | 50 |
| Consolidated Statements of Earnings and Comprehensive Income for the years ended June 30 2026, 2025, and 2024 | 54 |
| Consolidated Balance Sheets as of June 30, 2026 and 2025 | 55 |
| Consolidated Statements of Shareholders’ Equity for the years ended June 30, 2026, 2025, and 2024 | 56 |
| Consolidated Statements of Cash Flows for the years ended June 30, 2026, 2025, and 2024 | 57 |
| Notes to Consolidated Financial Statements | |
| Note 1. Description of Business and Summary of Significant Accounting Policies | 58 |
| Note 2. Revenue Recognition | 64 |
| Note 3. Supplemental Balance Sheet and Cash Flow Information | 66 |
| Note 4. Acquisitions | 68 |
| Note 5. Fair Value Measurements | 69 |
| Note 6. Debt and Other Financing Arrangements | 73 |
| Note 7. Leases | 73 |
| Note 8. Supplemental Equity and Accumulated Other Comprehensive Loss Information | 75 |
| Note 9. Earnings Per Share | 77 |
| Note 10. Share-based Compensation and Other Benefit Plans | 77 |
| Note 11. Other Income/(Expense) | 80 |
| Note 12. Income Taxes | 80 |
| Note 13. Segment Information | 84 |
| Note 14. Restructurings | 87 |
| Note 15. Subsequent Events | 92 |
| | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.